Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
74 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Cerus Corporation’s names, not what it holds today.
Patents granted
74
72 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
3
Against 5 in 2024 and 1 in 2023
Applications published
51
3 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'08'09'10'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology8
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Cerus Corporation its own name
US, as the owner printed on each patent
21 publishedCerus Corporation its own name
named as the applicant on its applications, in US
30 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jul 1, 2025 | 12,343,436 | System and methods for implementing a biological fluid treatment device | Medical technology | Cerus Corporation |
| Apr 22, 2025 | 12,282,015 | Systems and methods for testing and screening using compound bound substrates | Analysis of biological materials | Cerus Corporation |
| Feb 4, 2025 | 12,214,092 | Systems and methods for treating biological fluids | Medical technology | Cerus Corporation |
| Sep 17, 2024 | D1,042,788 | Illuminator device | | Cerus Corporation |
| Aug 20, 2024 | 12,064,537 | Kits and methods for preparing pathogen-inactivated platelet compositions | Medical technology | Cerus Corporation |
| Jul 16, 2024 | D1,035,969 | Illuminator device | | Cerus Corporation |
| Jun 18, 2024 | 12,011,510 | Biological fluid treatment systems | Medical technology | Cerus Corporation |
| Jan 30, 2024 | 11,883,544 | System and methods for implementing a biological fluid treatment device | Medical technology | Cerus Corporation |
| Jan 17, 2023 | 11,554,185 | Systems and methods for treating biological fluids | Medical technology | Cerus Corporation |
| Feb 1, 2022 | 11,235,090 | Kits and methods for preparing pathogen-inactivated platelet compositions | Medical technology | Cerus Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 25, 2025 | 2025/0388642 | COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES | Medical technology | Cerus Corporation |
| Nov 13, 2025 | 2025/0345471 | SYSTEMS AND METHODS FOR TREATING BIOLOGICAL FLUIDS | Medical technology | Cerus Corporation |
| Jul 3, 2025 | 2025/0216379 | SYSTEMS AND METHODS FOR TESTING AND SCREENING USING COMPOUND BOUND SUBSTRATES | Analysis of biological materials | Cerus Corporation |
| Oct 24, 2024 | 2024/0350687 | BIOLOGICAL FLUID TREATMENT SYSTEMS | Medical technology | Cerus Corporation |
| Aug 15, 2024 | 2024/0271094 | COMPOSITIONS AND METHODS FOR PATHOGEN INACTIVATION OF PLATELETS | Medical technology | Cerus Corporation |
| May 30, 2024 | 2024/0173351 | PLASMA COMPOSITIONS AND METHODS OF USE THEREOF | Pharmaceuticals | Cerus Corporation |
| Apr 4, 2024 | 2024/0108767 | SYSTEM AND METHODS FOR IMPLEMENTING A BIOLOGICAL FLUID TREATMENT DEVICE | Medical technology | Cerus Corporation · patent 12,343,436 granted from it |
| Dec 21, 2023 | 2023/0408490 | SYSTEMS AND METHODS FOR TESTING AND SCREENING USING COMPOUND BOUND SUBSTRATES | Analysis of biological materials | Cerus Corporation · patent 12,282,015 granted from it |
| Aug 24, 2023 | 2023/0263833 | COMPOSITIONS AND METHODS FOR PREPARATION OF RED BLOOD CELLS | Pharmaceuticals | Cerus Corporation |
| Jul 20, 2023 | 2023/0226232 | SYSTEMS AND METHODS FOR TREATING BIOLOGICAL FLUIDS | Medical technology | Cerus Corporation · patent 12,214,092 granted from it |
What it applied for, 2024 to 2025: Medical technology 5 · Pharmaceuticals 1 · Analysis of biological materials 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.